TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma

Overview of attention for article published in Molecular Cancer, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 22 X posts from 21 X users, with an upper bound of 180,595 followers.

RT @IamLinghua: Our new #SingleCell paper with ⁦@michaelwangmd⁩ out today shows TIGIT/PVR axis mediates relapse to #CART cell therapy in pa…

RT @IamLinghua: Our new #SingleCell paper with ⁦@michaelwangmd⁩ out today shows TIGIT/PVR axis mediates relapse to #CART cell therapy in pa…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 18 additional X posts.